On Monday, the FDA approved GW Pharmaceuticals' Epidiolex, a medication that treats two rare forms of epilepsy. Made of cannabidiol (CBD), a chemical found in the cannabis plant that does not have psychoactive effects, it is the first marijuana-derived drug to receive a green light from the agency.
The approval answers one question but raises others.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,